1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SLC39A13 CTRPv2 pan-cancer AAC -0.16 0.0004
mRNA ZBTB4 CTRPv2 pan-cancer AAC -0.16 0.0001
mRNA KIF3B CTRPv2 pan-cancer AAC -0.16 0.0001
mRNA GRAMD3 CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA TNFAIP2 CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA MYOF CTRPv2 pan-cancer AAC -0.15 0.0005
mRNA UBE2H CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA PXDC1 CTRPv2 pan-cancer AAC -0.15 0.0005
mRNA PIGT CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA CHD6 CTRPv2 pan-cancer AAC -0.15 5e-05
Download CSV